Cartesian Therapeutics (RNAC) Non Operating Interest Expenses (2015 - 2026)
Cartesian Therapeutics (RNAC) reported Non Operating Interest Expenses of $852,000 for Q2 2026.
Powered by 
Analysis
Cartesian Therapeutics (RNAC) Non Operating Interest Expenses (2015 - 2026) Analysis & Trends
For FY2023, Cartesian Therapeutics posted Non Operating Interest Expenses of $2.83 million, down 6.5% from FY2022.
- Non Operating Interest Expenses has a five-year compound annual growth rate of 13.7% (FY2018 to FY2023).
- By year, Non Operating Interest Expenses came in at $3.03 million in FY2022 (+6.6%), $2.84 million in FY2021 (+82.8%), $1.56 million in FY2020 (+2.4%) and $1.52 million in FY2019 (+1.7%).
- The Q2 2026 figure ranks as the highest quarterly Non Operating Interest Expenses since Q3 2023.
- The high point for year-over-year Non Operating Interest Expenses in five years was Q3 2021 (growth of 94.8%); the low point was Q1 2022 (a decline of 0.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Cartesian Therapeutics | 216.57 Mn | 216.57 Mn | - | 852,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 852,000.00 |
| Sep 30, 2023 | 1.27 Mn |
| Jun 30, 2023 | 752,000.00 |
| Mar 31, 2023 | 808,000.00 |
| Dec 31, 2022 | 807,000.00 |
| Sep 30, 2022 | 802,000.00 |
| Jun 30, 2022 | 715,000.00 |
| Mar 31, 2022 | 707,000.00 |
| Dec 31, 2021 | 711,000.00 |
| Sep 30, 2021 | 711,000.00 |
| Jun 30, 2021 | 711,000.00 |
| Mar 31, 2021 | 711,000.00 |
| Dec 31, 2020 | 713,000.00 |
| Sep 30, 2020 | 365,000.00 |
| Jun 30, 2020 | 205,000.00 |
| Mar 31, 2020 | 273,000.00 |
| Dec 31, 2019 | 335,000.00 |
| Sep 30, 2019 | 388,000.00 |
| Jun 30, 2019 | 400,000.00 |
| Mar 31, 2019 | 396,000.00 |
API Access
Cartesian Therapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=RNAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "RNAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=RNAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();